Corona Remedies IPO Subscription
The Corona Remedies IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
As per the latest subscription update, the Corona Remedies IPO has received bids for 62,65,41,440 shares against 45,71,882 shares offered, resulting in an overall subscription of 137.04x. the NII category is subscribed 208.88x, Retail Investors 28.73x, Employees 14.72x, and QIBs 278.52x. Within the NII category, BNII is subscribed 234.02x, while SNII is subscribed 158.62x.
- Retail
- 28.73x
- NII
- 208.88x
- QIB
- 278.52x
- Total
- 137.04x
Current GMP
₹342 (+32.20%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Corona Remedies IPO Subscription Details ( Wed, 10 Dec 25 01:53 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1,288,732 | 358,939,448 | 278.52x |
| Non-Institutional | 966,549 | 201,897,066 | 208.88x |
| BNII (>₹10L) | 644,366 | 150,793,356 | 234.02x |
| SNII (₹2L–₹10L) | 322,183 | 51,103,710 | 158.62x |
| Retail Investors | 2,255,281 | 64,802,038 | 28.73x |
| Employees | 61,320 | 902,888 | 14.72x |
| Total | 4,571,882 | 626,541,440 | 137.04x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 0 | - |
| BNII (>₹10L) | - | 0 | - |
| SNII (₹2L–₹10L) | - | 0 | - |
| Retail Investors | - | 0 | - |
| Employees | - | 0 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Corona Remedies IPO Live Subscription Status?
You can check the Corona Remedies IPO live subscription status on the IPO Master App or the official websites of the BSE,NSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Corona Remedies IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Corona Remedies IPO was subscribed 28.73 times as of Wed, Dec 10, 2025 07:23 PM. The public issue closed on Wed, Dec 10, 2025 for bidding.
How to subscribe Corona Remedies IPO?
Investors can apply for the Corona Remedies IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Corona Remedies IPO subscribed?
The Corona Remedies IPO was subscribed 137.04x times at the close of bidding period on Wed, Dec 10, 2025.
How to check Corona Remedies IPO allotment?
The Corona Remedies IPO allotment was finalized on Thu, Dec 11, 2025. You can check the Corona Remedies IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Corona Remedies IPO Be Listed?
The Corona Remedies IPO was listed on Mon, Dec 15, 2025, on the BSE,NSE.
What is the Corona Remedies IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Corona Remedies IPO was subscribed 278.52 times as of Wed, Dec 10, 2025 07:23 PM.